Press release
Global Tenofovir Disoproxil Market Projected to Grow at 5.3% CAGR, Reaching $4.61 Billion by 2029
Tenofovir Disoproxil
What Will the Tenofovir Disoproxil Industry Market Size Be by 2025?
The market size for tenofovir disoproxil has been displaying a steady upward trend in recent times. It is projected to surge from $3.58 billion in 2024 to $3.76 billion in 2025, with a compound annual growth rate (CAGR) of 4.9%. Key factors that contributed to growth over the historical period include heightened awareness and early diagnosis of viral infections, an increased prevalence of hepatitis b infections, the proliferation of generic drug production for tenofovir disoproxil, a rising count of clinical trials validating tenofovir efficacy, and increased healthcare funding for infectious disease care.
What's the Long-Term Growth Forecast for the Tenofovir Disoproxil Market Size Through 2029?
There is a strong projection of positive expansion for the tenofovir disoproxil market in the upcoming years. This market is estimated to elevate to a significant " $4.61 billion by 2029 with a compound annual growth rate (CAGR) of 5.3%. The increase during the forecast period is largely due to factors such as heightened demand for long-lasting tenofovir formulations and an amplified focus on combination therapies employing new antivirals. Additionally, a surge in regulatory approvals for innovative tenofovir combinations, an enhanced attention on pediatric versions of tenofovir, and a growing requirement for tenofovir in post-exposure prophylaxis also contribute. Foreseen trends in the forecast period consist of the emergence of unique drug delivery systems, the incorporation of artificial intelligence in drug evolution, advancements in combination therapies, progress in nanotechnology-based delivery, and innovations in fixed-dose combination therapies.
View the full report here:
https://www.thebusinessresearchcompany.com/report/tenofovir-disoproxil-global-market-report
What Are the Key Growth Drivers Fueling the Tenofovir Disoproxil Market Expansion?
The escalation in the occurrence of HIV and AIDS is anticipated to boost the expansion of the tenofovir disoproxil market in the future. This chronic viral infection called HIV and AIDS deteriorates the immune system by assaulting the CD4 cells, leaving the body susceptible to infections and illnesses. The escalating occurrence of HIV and AIDS can be attributed to factors like unprotected sex, insufficient knowledge, inadequate healthcare accessibility, and drug-resistant viruses. This increasing prevalence is heightening the demand for tenofovir disoproxil, a significant antiretroviral drug used for treatment and prevention. Case in point, a report published by the Joint United Nations Programme on HIV/AIDS (UNAIDS), a Switzerland-located government organization, in July 2024 stated that by the end of 2022, roughly 39.5 million people globally were affected by HIV, with about 1.3 million new infections that year. Further, around 630,000 deaths in 2022 were caused due to AIDS-related diseases. Moreover, in 2023, an estimated 39.9 million (36.1 million-44.6 million) people were afflicted with HIV worldwide. Consequently, the escalating occurrence of HIV and AIDS is fueling the growth of the tenofovir disoproxil market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21296&type=smp
What Are the Key Trends Driving Tenofovir Disoproxil Market Growth?
Major players in the tenofovir disoproxil marketplace are shifting their focus towards the creation of new treatment variations. These include combination therapy, aiming to enhance HIV/AIDS treatment and gain a competitive advantage. Combination therapy involves using two or more treatments concurrently to boost therapeutic impact and improve patient results for certain diseases. For example, Gilead Sciences Inc., a bio-pharmaceutical corporation based in the US, received approval from the U.S. Food and Drug Administration (FDA) in July 2022 for their drug, Vemlidy (tenofovir alafenamide), intended for treating chronic hepatitis B virus (HBV) infection in pediatric patients of six years and above, weighing a minimum of 25 kgs and diagnosed with stable liver disease. Vemlidy's sanction for this younger age bracket relied on Phase II clinical trial data, demonstrating the drug's safety and effectiveness for children as young as six years old.
How Is the Tenofovir Disoproxil Market Segmented?
The tenofovir disoproxil market covered in this report is segmented -
1) By Type: Tablet, Powder
2) By Distribution Channel: Online Pharmacies, Retail Pharmacies, Wholesalers Or Distributors
3) By Application: Hospital, Clinic
Subsegments:
1) By Tablet: Single-Drug Tablets, Fixed-Dose Combination Tablets
2) By Powder: Oral Powder, Reconstitutable Powder
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=21296&type=smp
Which Companies Are Leading the Charge in Tenofovir Disoproxil Market Innovation?
Major companies operating in the tenofovir disoproxil market are Gilead Sciences Inc., Viatris Inc., Teva Pharmaceuticals Limited, Cipla Ltd, Lupin Limited, Mylan NV, Blanver, SMS Pharmaceuticals, Bajaj Healthcare, Mangalam Drugs & Organics Ltd, Nortec Quimica, Arene Lifesciences, Cdymax, HRV Global Life Sciences, Pipelinepharma, Qilu Pharmaceutical, Jai Radhe Sales, Sinoway Industrial Co. Ltd, Aurisco Pharmaceutical, Huangshi Fuertai Pharmaceutical Tech Co. Ltd
Which Regions Are Leading the Global Tenofovir Disoproxil Market in Revenue?
North America was the largest region in the tenofovir disoproxil market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tenofovir disoproxil market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21296
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Speak With Our Expert:
Saumya Sahay,
Americas: +1 310-496-7795,
Asia: +44 7882 955267 & +91 8897263534,
Europe: +44 7882 955267,
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Tenofovir Disoproxil Market Projected to Grow at 5.3% CAGR, Reaching $4.61 Billion by 2029 here
News-ID: 4184008 • Views: …
More Releases from The Business Research Company
Rise In Musculoskeletal Disorders Fueling The Growth Of The Market Due To Aging …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Nimesulide Dispersible Tablet Market Size Growth Forecast: What to Expect by 2025?
The market size for nimesulide dispersible tablets has seen robust growth in the past few years, and the trend is anticipated to continue. The market is projected to see an increase from $0.77 billion in 2024 to…
Emerging Trends to Drive Cholinesterase (ChE) Inhibitors Market Growth at 7.4% C …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Cholinesterase (ChE) Inhibitors Market Size Growth Forecast: What to Expect by 2025?
In the recent past, there has been a substantial growth in the market size of cholinesterase (ChE) inhibitors. The market is projected to expand from a value of $3.92 billion in 2024 to around $4.2 billion in…
Global Venlafaxine Market Projected to Grow at 4.5% CAGR, Reaching $4.13 Billion …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Venlafaxine Industry Market Size Be by 2025?
In the last few years, the venlafaxine market size has experienced steady growth. Projected growth from $3.33 billion in 2024 to $3.47 billion in 2025, with a compound annual growth rate (CAGR) of 4.1%, mirrors this trend. Factors contributing…
Microtubule Inhibitor Chemotherapy Drugs Market Expansion Continues, with Foreca …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Microtubule Inhibitor Chemotherapy Drugs Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In the past few years, the market size for the chemotherapy drugs known as microtubule inhibitors has seen powerful growth. The market, which stood at $5.17 billion in 2024, is projected to expand…
More Releases for Tenofovir
A Deep Dive into Tenofovir Disoproxil Market 2025: Key Drivers, Growth Factors, …
Which drivers are expected to have the greatest impact on the over the tenofovir disoproxil market's growth?
The increasing prevalence of HIV and AIDS is expected to propel the growth of the tenofovir disoproxil market. HIV and AIDS are chronic viral infections that weaken the immune system by attacking CD4 cells, leaving the body vulnerable to infections and diseases. The increasing prevalence of HIV and AIDS is driven by factors such…
A Deep Dive into Tenofovir Disoproxil Market 2025: Key Drivers, Growth Factors, …
Which drivers are expected to have the greatest impact on the over the tenofovir disoproxil market's growth?
The increasing prevalence of HIV and AIDS is expected to propel the growth of the tenofovir disoproxil market. HIV and AIDS are chronic viral infections that weaken the immune system by attacking CD4 cells, leaving the body vulnerable to infections and diseases. The increasing prevalence of HIV and AIDS is driven by factors such…
Emtricitabine and Tenofovir Market Growing Rapidly by 2031 - Gilead Sciences, Ci …
The Emtricitabine/Tenofovir market is projected to grow at a compound annual growth rate (CAGR) of 5% during the forecast period from 2024 to 2031.
Emtricitabine/Tenofovir, marketed under the brand name Truvada, is a fixed-dose combination antiretroviral medication used for the treatment and prevention of HIV/AIDS. This combination consists of two antiretroviral drugs: Emtricitabine, a nucleoside reverse transcriptase inhibitor (NRTI), and Tenofovir disoproxil, a nucleotide reverse transcriptase inhibitor (NtRTI). Together, these medications…
Emtricitabine and Tenofovir Market 2024 Projections, Trends and Forecast 2024 - …
"Emtricitabine and Tenofovir Market 2024,"
The objectives outlined in the report are multifaceted and aimed at offering a comprehensive understanding of the Emtricitabine and Tenofovir market dynamics. These objectives encompass a meticulous analysis and forecast of the market's dimensions, encompassing both its value and volume aspects. Additionally, the report seeks to discern and delineate the market shares held by major segments within the Emtricitabine and Tenofovir industry, providing stakeholders with a…
Tenofovir Disoproxil Fumarate Drug Substance Market: Extensive Analysis and Grow …
Los Angeles, United States,- The research study presented here is a brilliant compilation of different types of analysis of critical aspects of the global Tenofovir Disoproxil Fumarate Drug Substance market. It sheds light on how the global Tenofovir Disoproxil Fumarate Drug Substance market is expected to grow during the course of the forecast period. With SWOT analysis and Porter's Five Forces analysis, it gives a deep explanation of the strengths and…
Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market to 2025 | Hospital …
Market Research Hub (MRH) has actively included a new research study titled Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Insights, Forecast to 2025 to its wide online repository. The concerned market is discoursed based on a variety of market influential factors such as drivers, opportunities and restraints. This study tends to inform the readers about the current as well as future market scenarios extending up to the period until forecast period limit; 2025.…
